Radiocobalt-based theranostics has emerged as a promising platform in nuclear medicine that offers dual capabilities for both diagnostic imaging and targeted radionuclide therapy. 55Co (t1/2 = 17.53 h, β+ = 77%, E γ = 931.1 keV, I γ = 75%) and 58mCo (t1/2 =... ...

请注册登录后继续浏览